VANCOUVER, BRITISH COLUMBIA--(Marketwire - August 06, 2008) - Tekmira Pharmaceuticals Corporation (TSX: TKM) reported that Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY), one of the company’s collaboration partners, announced today that it is on track to file an Investigational New Drug (IND) application before the end of 2008 for a product candidate that includes Tekmira’s SNALP delivery technology.
